Progressive myelin oligodendrocyte glycoprotein-associated demyelination mimicking leukodystrophy
Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) may be associated with relapsing disease, but clinical progression independent of relapse activity is rare. Objectives: To report progressive disease in a patient with MOGAD. Methods: A single retrospective case repo...
Gespeichert in:
Veröffentlicht in: | Multiple sclerosis 2022-08, Vol.28 (9), p.1481-1484 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background:
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) may be associated with relapsing disease, but clinical progression independent of relapse activity is rare.
Objectives:
To report progressive disease in a patient with MOGAD.
Methods:
A single retrospective case report.
Results:
At 4 years of age, the patient had a single episode of acute disseminated encephalomyelitis. She remained well until age 17 years but over the next 9 years developed progressive spastic quadriparesis, cognitive and bulbar dysfunction. Brain imaging showed a leukodystrophy-like pattern of white matter abnormality with contrast enhancement at different time points. Myelin oligodendrocyte glycoprotein (MOG)-IgG was repeatedly positive by live cell-based assay.
Conclusion:
Secondary progression may be a rare presentation of MOG-IgG-associated disease. |
---|---|
ISSN: | 1352-4585 1477-0970 |
DOI: | 10.1177/13524585221090737 |